ArticleFrontiers in medicine2022

AAV8-mediated sVEGFR2 and sVEGFR3 gene therapy combined with chemotherapy reduces the growth and microvasculature of human ovarian cancer and prolongs the survival in mice.

Anni Kujala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.